![Jing Qian](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jing Qian
Director/Board Member at
ANTENGENE CORPORATION LIMITED
Net worth: - $ as of 2026-05-30
Profile
Jing Qian is currently an Independent Non-Executive Director at Antengene Corporation Co., Ltd. and Antengene Corp.
Ltd., and a Partner at TruMed Investment Management Ltd. Former positions include Director at Baxter (China) Investment Co. Ltd. from 2009 to 2010, Associate at The Boston Consulting Group, Inc. from 1999 to 2002, Vice President-Business Development at Boehringer Ingelheim Pharmaceuticals, Inc. from 2010 to 2012, Principal at Eight Roads Capital Advisors (Hong Kong) Ltd. from 2012 to 2013, Project Manager at Mckinsey & Co. (China) from 2005 to 2008, and Partner at Pivotal Bioventure Partners China Advisor (Beijing) Co. Ltd. from 2018 to 2023.
Education includes an undergraduate degree (1996) and a graduate degree (1999) from East China Normal University, and an MBA from The Wharton School of the University of Pennsylvania (2004).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-10-01 | 0 ( -.--% ) | - $ | 2026-05-30 |
Jing Qian active positions
| Companies | Position | Start |
|---|---|---|
| ANTENGENE CORPORATION LIMITED | Director/Board Member | 2020-11-08 |
Antengene Corporation Co., Ltd.
 Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | - |
TruMed Investment Management Ltd. | Corporate Officer/Principal | 2023-12-31 |
Former positions of Jing Qian
| Companies | Position | End |
|---|---|---|
Pivotal Bioventure Partners China Advisor (Beijing) Co. Ltd.
 Pivotal Bioventure Partners China Advisor (Beijing) Co. Ltd. Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | 2023-11-30 |
Eight Roads Capital Advisors (Hong Kong) Ltd.
 Eight Roads Capital Advisors (Hong Kong) Ltd. Investment ManagersFinance Eight Roads Capital invests in companies located in China. The firm target companies operating in the fields of therapeutics, healthcare services, healthcare IT, digital health, and medical technology sectors. It provides financing for seed, early, and later stage capital requirements. | Corporate Officer/Principal | 2013-11-30 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Corporate Officer/Principal | 2011-12-31 |
Baxter (China) Investment Co. Ltd.
 Baxter (China) Investment Co. Ltd. Financial ConglomeratesFinance Provides investment services | Director/Board Member | 2010-02-28 |
Mckinsey & Co. (China)
 Mckinsey & Co. (China) Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Corporate Officer/Principal | 2008-11-30 |
Training of Jing Qian
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
91
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Eight Roads Capital Advisors (Hong Kong) Ltd.
Eight Roads Capital Advisors (Hong Kong) Ltd. Investment ManagersFinance Eight Roads Capital invests in companies located in China. The firm target companies operating in the fields of therapeutics, healthcare services, healthcare IT, digital health, and medical technology sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
East China Normal University
 East China Normal University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mckinsey & Co. (China)
Mckinsey & Co. (China) Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baxter (China) Investment Co. Ltd.
Baxter (China) Investment Co. Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Antengene Corporation Co., Ltd.
Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Pivotal Bioventure Partners China Advisor (Beijing) Co. Ltd.
Pivotal Bioventure Partners China Advisor (Beijing) Co. Ltd. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Antengene Corp. Ltd.
 Antengene Corp. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes hematologic malignancies therapies | Health Technology |
TruMed Investment Management Ltd. |
- Stock Market
- Insiders
- Jing Qian
